BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37846678)

  • 21. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia.
    Wen J; Xu F; Zhou Q; Shi L; Liu Y; Yue J; Zhang Y; Liang X
    Front Oncol; 2022; 12():895777. PubMed ID: 36185183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M; Gürsoy V; Hunutlu FC; Erkan B; Demirci U; Bas V; Gulsaran SK; Pinar IE; Ersal T; Kirkizlar TA; Atli EI; Kirkizlar HO; Ümit EG; Gürkan H; Ozkocaman V; Ozkalemkas F; Demir AM; Ali R
    Ann Hematol; 2022 May; 101(5):1049-1057. PubMed ID: 35190843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia.
    Cao M; Li T; He Z; Wang L; Yang X; Kou Y; Zou L; Dong X; Novakovic VA; Bi Y; Kou J; Yu B; Fang S; Wang J; Zhou J; Shi J
    Blood; 2017 Mar; 129(13):1855-1864. PubMed ID: 28053193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of early hemorrhage in acute promyelocytic leukemia.
    Naymagon L; Moshier E; Tremblay D; Mascarenhas J
    Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
    Chen X; Fan S; Zhao Y; Zhou J
    Clin Transl Oncol; 2021 Oct; 23(10):2171-2180. PubMed ID: 33942222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome".
    Nakamaki T; Hino K; Yokoyama A; Hisatake J; Tomoyasu S; Honma Y; Hozumi M; Tsuruoka N
    Anticancer Res; 1994; 14(3A):817-23. PubMed ID: 7521152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
    Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
    Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.
    Gill H; Yung Y; Chu HT; Au WY; Yip PK; Lee E; Yim R; Lee P; Cheuk D; Ha SY; Leung RYY; Ma ESK; Kumana CR; Kwong YL
    Blood Adv; 2021 Jul; 5(14):2829-2838. PubMed ID: 34269798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapies for newly diagnosed acute promyelocytic leukemia].
    Yokoyama Y
    Rinsho Ketsueki; 2020; 61(9):1166-1173. PubMed ID: 33162512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation syndrome and coagulation disorder - comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia.
    Luo JS; Zhang XL; Huang DP; Chen YQ; Wan WQ; Mai HR; Chen HQ; Wen H; Liu RY; Chen GH; Li Y; Luo XQ; Tang YL; Huang LB
    Ann Hematol; 2023 Jul; 102(7):1713-1721. PubMed ID: 37199788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group.
    Fenaux P; Le Deley MC; Castaigne S; Archimbaud E; Chomienne C; Link H; Guerci A; Duarte M; Daniel MT; Bowen D
    Blood; 1993 Dec; 82(11):3241-9. PubMed ID: 8241496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
    Mantha S; Tallman MS; Soff GA
    Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
    Altman JK; Rademaker A; Cull E; Weitner BB; Ofran Y; Rosenblat TL; Haidau A; Park JH; Ram SL; Orsini JM; Sandhu S; Catchatourian R; Trifilio SM; Adel NG; Frankfurt O; Stein EM; Mallios G; Deblasio T; Jurcic JG; Nimer S; Peterson LC; Kwaan HC; Rowe JM; Douer D; Tallman MS
    Leuk Res; 2013 Sep; 37(9):1004-9. PubMed ID: 23768930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prompt Initiation of Conventional Chemotherapy to Avoid Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia.
    Matsuda K; Oyama T; Maki H; Nakazaki K; Yasunaga M; Honda A; Masamoto Y; Kurokawa M
    Intern Med; 2023 Aug; 62(15):2181-2185. PubMed ID: 36476552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between D-Dimer/Fibrinogen Ratio and Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
    Li SS; Yang XW; Zheng Y; Gao YJ; Su YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1340-1344. PubMed ID: 37846682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia.
    Chu T; Wang H; Lv X; Qi J; Tang Y; Fan Y; Qiu H; Tang X; Fu C; Ruan C; Han Y; Wu DP
    Platelets; 2021 Jul; 32(5):677-683. PubMed ID: 32799612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.